Rational combination therapy in refractory migraine

B. Lee Peterlin, Anne H. Calhoun, Sherry Siegel, Ninan T. Mathew

Research output: Contribution to journalArticle

Abstract

Refractory migraine (RM) headaches pose important treatment challenges to the patients who live with them and the clinicians who try to treat them. Defined based on the lack of response to acute, preventive, and nonpharmacologic treatment, RM is often treated with a combination of treatments. Although combination therapy for RM has not been systematically studied in randomized trials, clinical experience suggests that a rational approach to RM treatment, utilizing a combination of treatments, may be effective where monotherapy has failed. In this article we briefly identify patient populations appropriate for more aggressive migraine prevention with combination therapy. We then discuss modifiable risk factors and comorbidities in migraine and then focus on the use of rational combination therapy, as well as the duration migraine preventatives should be considered for use. Future research is needed to evaluate the full potential of rational combination treatment as a strategy for treating and ultimately preventing RM.

Original languageEnglish (US)
Pages (from-to)805-819
Number of pages15
JournalHeadache
Volume48
Issue number6
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Migraine Disorders
Therapeutics
Comorbidity
Randomized Controlled Trials
Population

Keywords

  • Chronic migraine
  • Headache
  • Migraine
  • Migraine prevention
  • Rational combination therapy
  • Refractory migraine

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Peterlin, B. L., Calhoun, A. H., Siegel, S., & Mathew, N. T. (2008). Rational combination therapy in refractory migraine. Headache, 48(6), 805-819. https://doi.org/10.1111/j.1526-4610.2008.01142.x

Rational combination therapy in refractory migraine. / Peterlin, B. Lee; Calhoun, Anne H.; Siegel, Sherry; Mathew, Ninan T.

In: Headache, Vol. 48, No. 6, 06.2008, p. 805-819.

Research output: Contribution to journalArticle

Peterlin, BL, Calhoun, AH, Siegel, S & Mathew, NT 2008, 'Rational combination therapy in refractory migraine', Headache, vol. 48, no. 6, pp. 805-819. https://doi.org/10.1111/j.1526-4610.2008.01142.x
Peterlin BL, Calhoun AH, Siegel S, Mathew NT. Rational combination therapy in refractory migraine. Headache. 2008 Jun;48(6):805-819. https://doi.org/10.1111/j.1526-4610.2008.01142.x
Peterlin, B. Lee ; Calhoun, Anne H. ; Siegel, Sherry ; Mathew, Ninan T. / Rational combination therapy in refractory migraine. In: Headache. 2008 ; Vol. 48, No. 6. pp. 805-819.
@article{09b10d59e9dd4ca7a4d861649cfd0cd5,
title = "Rational combination therapy in refractory migraine",
abstract = "Refractory migraine (RM) headaches pose important treatment challenges to the patients who live with them and the clinicians who try to treat them. Defined based on the lack of response to acute, preventive, and nonpharmacologic treatment, RM is often treated with a combination of treatments. Although combination therapy for RM has not been systematically studied in randomized trials, clinical experience suggests that a rational approach to RM treatment, utilizing a combination of treatments, may be effective where monotherapy has failed. In this article we briefly identify patient populations appropriate for more aggressive migraine prevention with combination therapy. We then discuss modifiable risk factors and comorbidities in migraine and then focus on the use of rational combination therapy, as well as the duration migraine preventatives should be considered for use. Future research is needed to evaluate the full potential of rational combination treatment as a strategy for treating and ultimately preventing RM.",
keywords = "Chronic migraine, Headache, Migraine, Migraine prevention, Rational combination therapy, Refractory migraine",
author = "Peterlin, {B. Lee} and Calhoun, {Anne H.} and Sherry Siegel and Mathew, {Ninan T.}",
year = "2008",
month = "6",
doi = "10.1111/j.1526-4610.2008.01142.x",
language = "English (US)",
volume = "48",
pages = "805--819",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Rational combination therapy in refractory migraine

AU - Peterlin, B. Lee

AU - Calhoun, Anne H.

AU - Siegel, Sherry

AU - Mathew, Ninan T.

PY - 2008/6

Y1 - 2008/6

N2 - Refractory migraine (RM) headaches pose important treatment challenges to the patients who live with them and the clinicians who try to treat them. Defined based on the lack of response to acute, preventive, and nonpharmacologic treatment, RM is often treated with a combination of treatments. Although combination therapy for RM has not been systematically studied in randomized trials, clinical experience suggests that a rational approach to RM treatment, utilizing a combination of treatments, may be effective where monotherapy has failed. In this article we briefly identify patient populations appropriate for more aggressive migraine prevention with combination therapy. We then discuss modifiable risk factors and comorbidities in migraine and then focus on the use of rational combination therapy, as well as the duration migraine preventatives should be considered for use. Future research is needed to evaluate the full potential of rational combination treatment as a strategy for treating and ultimately preventing RM.

AB - Refractory migraine (RM) headaches pose important treatment challenges to the patients who live with them and the clinicians who try to treat them. Defined based on the lack of response to acute, preventive, and nonpharmacologic treatment, RM is often treated with a combination of treatments. Although combination therapy for RM has not been systematically studied in randomized trials, clinical experience suggests that a rational approach to RM treatment, utilizing a combination of treatments, may be effective where monotherapy has failed. In this article we briefly identify patient populations appropriate for more aggressive migraine prevention with combination therapy. We then discuss modifiable risk factors and comorbidities in migraine and then focus on the use of rational combination therapy, as well as the duration migraine preventatives should be considered for use. Future research is needed to evaluate the full potential of rational combination treatment as a strategy for treating and ultimately preventing RM.

KW - Chronic migraine

KW - Headache

KW - Migraine

KW - Migraine prevention

KW - Rational combination therapy

KW - Refractory migraine

UR - http://www.scopus.com/inward/record.url?scp=44849115002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44849115002&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2008.01142.x

DO - 10.1111/j.1526-4610.2008.01142.x

M3 - Article

C2 - 18549358

AN - SCOPUS:44849115002

VL - 48

SP - 805

EP - 819

JO - Headache

JF - Headache

SN - 0017-8748

IS - 6

ER -